Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04647526
Title Study Evaluating mCRPC Treatment Using PSMA [Lu-177]-PNT2002 Therapy After Second-line Hormonal Treatment (SPLASH)
Acronym SPLASH
Recruitment Active, not recruiting
Gender male
Phase Phase III
Variant Requirements No
Sponsors POINT Biopharma
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | SWE | NLD | GBR | FRA | CAN


No variant requirements are available.